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Carcinogenicity of Chloroform
by Melvin Dwaine Reuber*
Chloroform iscarcinogenic in rats, mice, and probably in dogs. Chloroform induced carcinomas ofthe
liver and kidney and malignant tumors in other organs in rats and mice. Liver neoplasms have been
described in three strainsofmice. Carcinomasofthe kidney were found in a first study in mice and in the
repeat ofthat study. Dogs given chloroform developed neoplasms ofthe liver as well as in other organs.
Rats given chloroform also developed toxic changes, particularly male rats, as a result of treatment.
These lesions included interstitial fibrosis of the kidney; polyarteritis of the mesenteric, pancreatic, and
other arterioles and arteries; and atrophy ofthe testes. These toxic changes may have interfered with the
development of neoplasms in male rats.
Introduction
Chloroform (CHCl3, trichloromethane) is used
chiefly in the manufacture of fluorocarbons for re-
frigerants, propellants, and plastics. However, there
are many other uses (1): chloroform is used as a
solvent in photographic processing and in dry
cleaning, as well as in the preparation ofantibiotics,
dyes, drugs, and pesticides. It is added to some
toothpastes, cough medicines, linaments, and
salves.
This review includes, to the best of our knowl-
edge, every study on the carcinogenicity of chloro-
form in animals. The results and conclusions for the
NCI chloroform-rat study and NCI chloroform-
mouse study are based on my examinations of the
histological sections. The results ofthe other studies
are my own analyses ofthe data which are, in most
cases, raw data. Other studies reviewed were:
Huntington Research Center chloroform studies,
Eschenbrenner study, Rudali study, and Roe study.
Statistical testsofsignificance werep (probability)
values obtainedwith Fisher's exact test and tests for
positive lineartrendand departure from lineartrend,
which are described in detail (2).
NCI Chloroform-Rat Study
Chloroform was administered orally to male and
female Osborne-Mendel rats, 50 ofeach sex, at two
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dose levels (1). Chloroform was given in corn oil by
gavage five times per week for 78 weeks. Rats were
started at 52 days ofage and killed after 111 weeks.
The high dose concentrations ofchloroform were
intended to be the maximal amount that the animals
could tolerate for 78 weeks; and the low doses were
one-halfofthehighdoses. These doses were initially
chosen on the basis of survival, weight gain, and
clinical observations during a trial 6-week study. As
the full-scale study progressed, it was decided to
reduce the dose given to the female rats.
The dose levelsformale rats were 90 or 180 mg/kg
ofbody weight. Female rats were given 125 or 250
mglkg for 22 weeks, at which time the doses were
changed to 90 or 180 mg/kg (with time weighted
average of 100 or 200 mg/kg for the study) (Table 1).
Groups of 20 rats of each sex received the corn oil
vehicle and other groups of 20 rats received no
treatment.
Necropsy was done on all rats. Complete his-
topathologic examinations were performed on killed
rats and whenever possible on those found dead.
Average survivaltimesformaleratsgiventhe high
dose chloroform was 80 weeks, and 83.6 weeks for
the females (Table 2). Control males survived for
80.5 weeks and control females for 95.6 weeks.
The results are based on my examination of the
histological sections. Results are presented for the
following: tumors ofthe liver, tumors ofthe kidney,
tumors of the thyroid, malignant tumors in other
organs, malignant tumors in-all organs, and lesions
other than tumors, and summary.
August 1979 171Table 1. Average dose levels ofchloroform for males and
females (NCI rat study).
Males Females
Low dose, mg/kg 90 100
High dose, mg/kg 180 200
Tumors of the Liver
Cholangiofibromas and cholangiocarcinomas
were present in the liver of 11 of39 females (28%) (p
= 0.00599)giventhe highdose ofchloroformand in 3
of39females (8%) given the low dose, whereas con-
trol ratsdidnotdevelopsuchtumors(Table3). There
were fewer lesions in male rats. Cholangiocar-
cinomas, which were well-differentiated histologi-
cally, invaded the adjacent hepatic tissue. The first
cholangiofibroma was found at 28 weeks.
Hyperplastic nodules and hepatocellular car-
cinomas developed in 36% (14 of 39) females given
the high dose (p = 0.03105) and 23%(9of39) females
receiving the low dose of chloroform, compared to
8%(3 of40)controls(Table4)(3). Fewersuchlesions
were seen inmale rats (Table 5). Iftime ofsurvival is
taken into consideration (i.e., time ofappearance of
first nodule or carcinoma, 32 weeks), then 14 of 32
highdosefemales (44%) and 9of29lowdosefemales
(31%) had hyperplastic nodules or hepatocellular
carcinomas. Hepatocellular carcinomas were well-
differentiated histologically.
Ifnumbers ofrats with tumors ofthe liveris taken
into consideration, then 51% (20 of 39) females re-
ceivingthehighdose(p = 0.00161) and26%(10of39)
females given the low dose of chloroform had such
tumors compared to 8% of the controls (Table 6).
Twelve of49(24%)high dose male rats, compared to
5%controls, had tumors ofthe liver(0.04877 testfor
positive trend).
Some male and female rats given the low or high
doses ofchloroform had focal areas of hyperplastic
parenchymal cells of the liver. Necrosis ofthe liver
was often present in rats dying early; however, cir-
rhosis was not observed in rats given chloroform.
Table 2. Survival times for males and females given
chloroform (NCI Rat Study)a
Survival time, weeks
Females, Males,
Treatment average (range) average (range)
0 95.6 (61-41O)b 80.5 (54-110)c
Vehicle 101.2 (29-111) 101.0 (67-110)
Low dose 91.1 (40-111) 97.5 (45-111)
High dose 83.6 (28-111) 80.0 (30-111)
aBased on time ofdevelopment offirst tumor ofthe liver at 28
weeks.
bFive rats were killed at 61 weeks.
CFour rats were killed at 61 weeks.
In summary, chloroform was carcinogenic for
liver of rats. Female rats were much more suscep-
tiblethanwere male ratsto the induction oftumorsof
both parenchymal cells and bile duct cells. Rats
given chloroform did not develop cirrhosis of the
liver.
Tumors of the Kidney
Carcinomas ofthe kidney were present in 12 of49
male rats (25%) given the high dose (p = 0.004861)
and 12% (6 of 50) receiving the low dose of chloro-
form compared toO0ointhe control rats(Table7) (4).
A few rats had both carcinomas ofthe cortex ofthe
kidney and the renal pelvis. Administration of
chloroform did not cause a significant increase in
tumors ofthe kidney infemale rats. The only hepatic
lesion associatedwith carcinomaofthe kidney was a
cholangiocarcinoma in one rat.
Carcinomas of the kidney were well-differen-
tiated, poorly differentiated, or undifferentiated.
Carcinomas invaded and replaced the adjacent renal
parenchymaand metastasized tootherorgans in two
male rats and one female rat. The carcinomas in fe-
males were undifferentiated.
Carcinomas of the kidney generally were as-
sociated with chronic interstitial nephritis. Ap-
proximately 75% ofthe carcinomas were associated
Table 3. Cholangiofibromas and cholangiocarcinomas of the liver in females given chloroform (NCI rat study)a
Treatment Cholangiofibroma Cholangiocarcinoma Total
0 0/20 (0%) 0/20 (0O)b 0/20 (0%)
Vehicle 0/20 (O%o) 0/20 (0%) 0/20 (0%)
Low dose 1/39 (3%) 2/39 (5%) 3/39 (8%)
High dose 3/39 (8%) 8/39(20%),p = 0.02774 11/39(28%),p = 0.00599
p = 0.0042c p = 0.00067
aStatistics using vehicle control unless otherwise stated.
bColony control was given as 0/98 (0%o).
"lest for positive trend unless otherwise specified.
Environmental Health Perspectives 172Table 4. Hyperplastic nodules and hepatocellular carcinomas in females given chloroform (NCI Rat Study).a
Hyperplastic Hepatocellular
Treatment nodules carcinomas Total
1/20 (5%)
2/20 (10%S)
7/39 (18%)
12/39 (31%)
p = 0.03617
0/20 (0%)b
0/20 (09o)
2/39 (5%)
2/39 (5%)
1/20 (5%)
2/20 (10%7o)
9/39 (23%)
14/39(36%),p = 0.03105
p = 0.01886
aBased on time of development of first tumor of the liver at 28 weeks.
bColony control was given as 0/98 (0%7).
with chronic renal disease, with 25% each being
mild, moderate, or severe in degree.
In summary, chloroform was carcinogenic for
kidney in male rats and not for female rats. By con-
trast, female rats were more susceptible to the de-
velopment ofhepatic tumors than male rats. Appar-
ently, chloroform was not as readily metabolized in
the liver of male rats and more chemical(s) reached
the kidney.
Tumors of the Thyroid
There were increased incidences of tumors ofthe
thyroid gland in females given the low or high doses
ofchloroform (Table 8). Tumors ofthe thyroid were
present in 11 of 39 (28%) low dose females (p =
0.03687)and 12of39(31%)highdosefemale rats(p =
0.02089). Male rats receiving the corn oil vehicle had
more tumors of the thyroid than either the control
rats notgivencornoil orthechloroform-treated male
rats (Table 9). Tumors in chloroform-treated rats
usually were larger than in the control rats and
sometimes invaded the adjacent tissue.
Tumors ofthe thyroid, liver, and/orkidney gener-
ally were not found, with a few exceptions, in the
same animal. One carcinoma of the thyroid was
present in a high dose female rat with cholangiocar-
cinoma, and one adenoma of the thyroid with
hepatocellular carcinoma in a high dose male rat.
However, rats with tumors of the thyroid generally
Table 5. Hyperplastic nodules and hepatocellular carcinomas
in males given chloroform (NCI Rat Study).
Hyperplastic Hepatocellular
Treatment nodules carcinomas Total
0 0/20 (0%/) 0/20 (07b)a 0/20 (0%)
Vehicle 1/19 (5%) 0/19 (0O) 1/19 (5%)
Low dose 5/50 (10%7o) 0/50 (0o) 5/50 (10%)
High dose 8/49 (16%) 2/49 (4%) 10/49 (20%)
p = 0.04502
aColony control was given as 1/99 (1%).
did not have tumors of the liver, or if they did, the
tumors were hyperplastic nodules (as in the case of
four low dose male rats). Three high dose male rats
with thyroid tumors also had renal cell carcinomas.
In summary, chloroform administration resulted
in a significant increase in tumors of the thyroid in
female rats. Rats with thyroid tumors generally did
not have tumors of the liver and kidney; however,
they rarely had hyperplastic nodulesofthe liver. The
latterfinding suggests that thyroid tumors may have
interfered with the development of hepatic car-
cinomas.
Malignant Tumors in Organs Other Than
Liver, Kidney, and Thyroid
The incidences of malignant tumors in organs
other than liver, kidney, and thyroid in chloroform-
treated rats were not increased, with one exception
(Tables 10and 11). Of50lowdose male rats, 24(48%)
had malignant tumors compared with 16% of the
controls (p = 0.00639). There were four splenic,
three subcutaneous, and one ostogenic sarcomas.
Thetumors were mostly sarcomas in ratsthat did not
have other tumors, in rats without chronic renal dis-
ease, and in rats that survived over 100 weeks.
Table 6. Tumors of the liver in males and females given
chloroform (NCI Rat Study).a
Treatment Males Females
0 0/20 (0o) 1/20 (5%)
Vehicle 2/19 (11%) 2/20 (10%o)
Low dose 5/50 (10%o) 10/39 (26%)b
High dose 12/49 (24%)C 20/39 (51%)d-, p = 0.00161
p = 0.04877 p = 0.0004352
aCombining all cholangiofibromas, hyperplastic nodules, and
carcinomas of the liver.
'Two rats had both parenchymal cell and bile duct cell tumors;
p = 0.02937 when compared with pooled controls.
'One rat had both a parenchymal cell and bile duct cell tumors;
p = 0.01233 when compared with pooled controls.
dFive rats had both parenchymal cell and bile duct cell tumors.
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Vehicle
Low dose
High doseTable 7. Tumors of the kidney in males given chloroform (NCI Rat Study).a
Treatment Renal cortex Renal pelvis Total
0 0/20 (O%o) 0/20 (O%o) 0/20 (O%o)a
Vehicle 0/19 (O0%) 0/19 (0%) 0/19 (0%7)
Low dose 6/50 (12%) 2/50 (4%) 6/50 (12%)b
High dose 12/49 (24%), p = 0.01267 2/49 (4%) 12/49 (25%)b, p = 0.004861
p = 0.004861 p = 0.004861
aColony control was given as 0/99 (O0%).
'Two male rats at each dose had both tumors.
Malignant Tumors in All Organs
There were slightly increased incidences ofmalig-
nant tumors in male and female rats given chloro-
form inboth the low and high dose groups (Tables 12
and 13). Malignant tumors were found in 25 of 50
(50%) low dose male rats given chloroform (p =
0.03070).
The incidences of high dose male and female and
low dose male and female rats are even more signifi-
cant when corrections are made for survival time,
i.e., takingintoconsideration the survival time ofthe
first rat to develop a malignant tumor (42 weeks)
(Tables 14 and 15). Malignant tumors were found in
72% of low dose female rats (p = 0.00969), 66% of
high dose female rats (p = 0.02816); 58% oflow dose
male rats (p = 0.00383), and 50%o of high dose male
rats (p = 0.03726). Control rats of both sexes had
approximately 30%o.
Carcinomas in high dose chloroform-treated
female rats were in the liver, thyroid, and mammary
gland, and in the mammary gland and endocrine
organs in low dose female rats. Carcinomas in male
rats were in the kidney and endocrine organs. Sar-
comas were observed in the spleen, lung, bone, and
subcutaneously. Carcinomas in control females
were in the mammary gland and endocrine organs.
Carcinomas in control male rats were in endocrine
organs.
Hyperplasia was occasionally seen in the pan-
creas, both of the acinar and islet cells, and a few
animals had nodules.
Lesions Other Than Tumors
Lesions other than tumors were observed more
often in chloroform-treated rats, particularly in
males, than inthe controls. These lesions were inter-
stitial fibrosis of the kidney; polyarteritis of the
mesenteric, pancreatic, and other arteries and ar-
terioles; and atrophy of the testes.
Polyarteritis developed in approximately one-
fourth of the male rats given chloroform. Poly-
arteritis was present in 22% low dose male rats (p =
0.0064), and 25% high dose male rats (p = 0.00322).
The lesion involved predominantly the mesenteric
and pancreatic arteries, as well as small arteries and
arterioles throughout the body in treated rats,
whereas in control rats polyarteritis was limited to
the mesenteric artery (Table 16). Thrombosis was
alsopresent in the mesenteric artery oftreated rats.
The mesenteric artery was examined only when the
arteritis was severe; and the incidence, particularly
ofless advancedarteritis, would probably have been
higher if the mesenteric artery were routinely sec-
tioned histologically. The lesion was generally as-
sociated with severe atrophy of the testes, severe
interstitial fibrosis of the kidney, and carcinoma of
the kidney.
Table 8. Tumors of the thyroid gland in females given chloroform (NCI Rat Study).a
Treatment Adenomas Carcinomas Total
0 1/20 (5%) 2/20 (10%) 3/20 (15%)b
1/40 (2.5%)c 3/40 (7.5%)c 4/40 (I0%)C
Vehicle 0/20 (O%o) 1/20 (5%) 1/20 (5%)
Low dose 8/39 (21%), p = 0.01299 3/39 (7%) 11/39 (28%), p = 0.03687
High dose 7/39 (18%), p = 0.025494 5/39 (13%) 12/39 (31%), p = 0.02089
p = 0.03186 p = 0.01914
aApproximately one-half of the tumors were F-cell and one-half C-cell adenomas and carcinomas.
bColony control was given as 1/98 (1%).
CStatistics based on combined controls.
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rats more often than female rats, and the lesion was
more severe in male rats. It was usually associated
with carcinomas of the kidney.
Atrophy of the testes was present in the chloro-
form-treated male rats and was extremely rare in the
control male rats (about 2%). The lesion was ob-
served in one-third of the chloroform-treated male
rats.
Summary
Chloroform is carcinogenic in rats. Chloroform
not only induced malignant tumors of the liver in
female rats and of the kidney in male rats, but in
other organs as well. There also are toxic changes,
particularly in male rats, as aresult ofthe treatment.
These toxic changes may have interfered with the
development of tumors in male rats.
Table 9. Tumors of the thyroid gland in males given chloroform (NCI Rat Study).a
Treatment Adenomas Carcinomas Total
0 0/20 (0o) 1/25 (4%) 1/20 (5%)b
Vehicle 2/19 (11%) 2/19 (11%) 4/19 (21%)
Low dose 3/50 (6%) 0/50 (0%), p = 0.07289c 3/50 (6%), p = 0.08491c
High dose 4/49 (8%) 3/49 (6%) 7/49 (14%)
aTumors generally were F-cell adenomas or carcinomas.
bColony control was given as 8/99 (8%).
'Two-tail.
Table 10 Carcinomas and sarcomas in other organs in males given chloroforma
Treatment Carcinomas Sarcomas Total
0 2120 (11%) 3/30 (15%) 5/20 (25%)
3/39 (8%)b 5/39 (13%) 8/39 (21%)
Vehicle 1/19 (5%) 2/19 (11%) 3/19 (16%)
Low dose 11/50 (22%), p = 0.05844 13/50 (26%) 24/50 (48%), p = 0.00639
High dose 5/49 (10%o) 8/49 (16%) 13/49 (27%)
p = 0.0033
aColony control incidences are not available.
bStatistics based on combined controls.
Table 11. Carcinomas and sarcomas in other organs in females given chloroform.a
Treatment Carcinomas Sarcomas Total
0 4/20 (20%) 0/20 (0%lo) 4/20 (20%)
Vehicle 4/20 (20%7b) 1/20 (5%) 5/20 (25%)
Low dose 10/39 (26%) 3/39 (8%) 13/39 (33%), p = 0.07071
High dose 5/39 (13%) 5/39 (13%) 12/39 (31%), p = 0.07071
p = 0.07113
aColony control incidences are not available.
Table 12. Carcinoma and sarcoma incidences of male rats ingesting chloroform (NCI Rat Study).a.b
Treatment Carcinomas Sarcomas Total
0 3/20 (15%) 3/30 (15%) 6/20 (30%'o)
6/39 (15%)c 5/39 (13%)c 11/39 (28%)c
Vehicle 3/19 (16%) 2119 (11%) 5/19 (26%)
Low dose 15/50 (30%1b) 13/50 (26%) 25/50 (S50%0)d, p = 0.03070
High dose 16/49 (32%) 8/49 (16%) 21/49 (43%)d
aColony control incidences are not available.
bOne rat was counted only once, regardless of the number of tumors.
CStatistics based on combined controls.
dSome rats had both carcinomas and sarcomas.
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Treatment Carcinomas Sarcomas Total
0 5/20 (25%) 0/20 (0%o) 5/20 (25%)
Vehicle 6/20 (30%) 0/20 (0%) 6/20 (30%)
Low dose 20/39 (51%) 3/39 (8%) 21/39 (54%),c p = 0.07071
High dose 19/39 (50%) 5/39 (13%) 21/39 (54%),c p = 0.07071
p = 0.07113
aColony control incidences are not available.
"One rat was counted only once regardless of the number of tumors.
CSome rats had both carcinomas and sarcomas.
Table 14. Carcinoma and sarcoma incidences (corrected for survival) of male rats ingesting chloroform (NCI Rat Study).
Treatment Carcinomas Sarcomas Total
0 3/20 (15%) 3/20 (15%) 6/20 (30%)
6/39 (15%)a 5/39 (13%)a 11/39 (28%)a
Vehicle 3/19 (16%) 2/20 (11%) 5/20 (26%)
Low dose 15/43 (35%) 13/43 (30%o), p = 0.04974 25/43 (58%),b p = 0.00583
High dose 16/42 (38%) 8/42 (19%) 21/42 (50%),bp = 0.03726
p = 0.07780 p = 0.0626 p = 0.03526
p = 0.0422c
aStatistics based on combined controls.
bSome rats had both carcinomas and sarcomas.
cDeparture from trend.
Table 15. Carcinomas and sarcoma incidences (corrected for survival) of female rats ingesting chloroform (NCI Rat Study).
Treatment Carcinomas Sarcomas Total
0 5/20 (25%) 0/20 (0%Y) 5/20 (25%)
Vehicle 6/18 (33%) 0/18 (0%) 6/18 (33%)
Low dose 20/29 (69%), p = 0.01815 3/29 (10%1o) 21/29 (72%),a p = 0.00969
High dose 19/32 (59%) 5/32 (13%) 21/32 (66%),a p = 0.02816
p = 0.0531b p = 0.06691 p = 0.03832
p = 0.462b
aSome rats had both carcinomas and sarcomas.
bDeparture from trend.
NCI Mouse-Chloroform Study
Chloroform was administered orally to four
groups each of B6C3 Fl mice (1). The groups con-
sisted of50 males and 50 females each at two doses.
The mice were started on the chemical at the age of
35 days. Chloroform was given in corn oil by gavage
daily five times a week for 78 weeks, and the mice
were killed at 92 weeks. Time and weighted average
doses are given in Table 17.
Complete necropsies were performed on all mice.
Histopathologic examinations were done on killed
mice and whenever possible on those found dead.
There was very little difference in the growth
curves for male and female mice given chloroform
and those not receiving the chemical. Food con-
sumption was also comparable.
Abdominal distention, apparently because of
hepatic tumors, was observed in female mice given
thehigh dose ofchloroform after42weeks and in the
high dose male mice after 78 weeks. All of the high
dose female mice developed abdominal distention,
compared with one-halfof the high dose male mice.
Carcinoma ofthe liver at autopsy was first observed
at 54 weeks.
Chloroform-treated mice survived well (Table 18).
There were no significant differences between the
control or chloroform-treated mice.
Results are based on my examination of the his-
tological section.
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chloroform (NCI Rat Study).
Treatment Males Females
0 1/20 (5%) 0/20 (0o)
1/39 (3%)
Vehicle 0/19 (0%70) 1/20 (5%)
Low dose 11/50 (22%) p = 0.00664 3/29 (8%)
High dose 12149 (25%) p = 0.00322 4/39 (13%)
p = 0.006036
aStatistics based on combined controls.
Table 17. Average dose levels ofchloroform
for males and females (NCI Mouse Study).
Males Females
Low dose, mg/kg 138 238
High dose, mg/kg 277 477
Table 18. Survival times for males and females
given chloroform (NCI Mouse Study).a
Survival time, weeks
Females, Males,
Dose average (range) average (range)
0 90.5 (70-92) 85.0 (75-91)
Vehicle 89.9 (68-92) 86.7 (72-92)
Low dose 90.0 (65-93) 89.0 (61-92)
High dose 85.4 (67-93) 88.3 (54-92)
aBased on time ofdevelopment offirst tumor ofthe liver at 54
weeks.
Tumors of the Liver in Female Mice
Female mice given chloroform developed tumors
ofthe liver, and mostofthe tumors were carcinomas
(Table 19). Everyfemale mouse (40/40given the high
dose (p = 0.00001), and 40of45 female mice (90%) (p
= 0.00001) receiving the low dose developed car-
cinomas of the liver.
Female mice on the high dose of chloroform had
two or three carcinomas per liver, and the car-
cinomas were well-differentiated, poorly differ-
entiated, or undifferentiated hepatocellular car-
cinomas. Two mice also had cholangiocarcinomas.
The carcinomas in female mice on the low dose of
chloroform wereusually solitary, well-differentiated
carcinomas. There was invasion ofadjacent hepatic
tissuebythecarcinomas, and metastases tothe lungs
were found in two high dose female mice. Many of
the carcinomas in high dose female mice were com-
pletely necrotic. Some ofthe pedunculated necrotic
(infarcted) tumors hadtwisted ontheirsmallpedicles
and obstructed their blood supply; however, the
cause ofnecrosis ofmost carcinomas was not appar-
ent. Cirrhosis was not noted in the liver even though
some mice had bile duct proliferation and focal ne-
crosis. One of the possible causes for necrosis of
these carcinomas ofthe liver would be hepatic vein
thrombosis.
Tumors of the Liver in Male Mice
Male mice administered chloroform also de-
veloped high incidences of hepatic tumors (Table
20). Every male mouse (44/44) (p = 0.00001) receiv-
ing the high dose and 20 of46 male mice (43%) (p =
0.00001) on the low dos3 of chloroform had car-
cinomas of the liver. There were hyperplastic
nodules in an additional 11 male mice (24%) on the
low dose. There were fewer carcinomas per liver in
male mice, and the carcinomas tended to be smaller
and not as malignant as in the female mice given
chloroform. Two male mice had metastases to the
lungs from hepatic carcinomas. Necrosis of car-
cinomas ofthe liver was rare in male mice. Cirrhosis
of the liver was not present in these mice.
Malignant Lymphomas
Malignant lymphomas were observed in 14 of 46
male mice(30%)receivingthe lowdose (p = 0.00642)
and in 10of44malemice(23%)giventhe highdose (p
Table 19. Incidences of hepatic lesions in females given chloroform (NCI Mouse Study).
Hyperplastic Small Large
Dose nodules carcinomas carcinomas Total
0 0/20 (0%) 0/20 (0o) 0/20 (0o) 0/20 (0%)
Vehicle 0/19 (0%1) 0/19 (0O) 0/19 (0O) 0/19 (0%X0)
Low dose 1/45 (2%) 3/45 (7%) 37/45 (82%), p = <0.00001 41/45 (91%), p = <0.00001
High dose 0/40 (09%o) 1/40 (2%) 39/40 (98%), p = <0.00001 40/40(000o),a p = <0.00001
p = 3.914 x 10-15 p = 2.168 x 10-18
p = 0.0002b p = <000001b
aTwo mice had metastases to the lungs.
bDeparture from trend.
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Hyperplastic Small Large
Dose nodules carcinomas carcinomas Total
0 1/17 (6%) 1/17 (6%) 1/17 (6%) 3/17 (18%)
1/34(3%)8 5/34 (15%)
Vehicle 2/17 (12%) 0/17 (0%o) 0/17 (0%7o) 2/17 (12%)
Low dose 11/46 (24%) 3/46 (7%) 17/46 (37%), p = 0.00018 31/46 (67%),b p = <0.00001
High dose 0/44 (0%o) 3/44 (7%) 41/44 (93%), p = <0.00001 44/44 (100%), p = <0.00001
p = 1.313 x 10-18 p = 5.794 x 10-17
aStatistics based on combined controls.
1Two mice had metastases to the lungs.
= 0.02751) of chloroform (Table 21). Lymphomas
were not present in male mice given the vehicle or in
control mice. The incidence of lymphomas was sig-
nificantly increased in chloroform-treated female
mice given the low dose (9 of 45) (p = 0.03217).
hyperplasia of the endometrium in low dose and
control female mice. There was focal adenocar-
cinoma, which was present slightly more often in the
chloroform-treated female mice. Stromal cell
hyperplasia ofthe endometrium was more common
in the low dose treated females.
Tumors Other Than Liver and Lymphomas
Al II l^ T.
Malignant tumors, other than carcinomas of the
liver and lymphomas, were slightly increased in the
low dose male and female mice (Table 22). Such
tumors were seen in 11 of45 female mice (24%) (p =
0.06747) compared to 1 of 12 vehicle control mice.
Carcinomas presentmainlyinthedigestive system(5
of45 mice), but also in the endocrine organs, lung,
and kidney. Four unusual carcinomas occurred at
the anal-rectal junction - three sebaceous car-
cinomas and one mixed sebaceous and adenocar-
cinoma. There was an adenocarcinoma of the
stomach at the squamous glandular junction. The
incidence of lesions at the anal-rectal junction may
well have been higher, because this area was exam-
ined histologically only when a tumor was observed
grossly. Malignant tumors, other than liver or lym-
phoma,generallyoccurred inthe lowdose male mice
without carcinomas of the liver; however, an occa-
sional mouse had asmall solitary hepatic carcinoma.
By contrast, malignant tumors in the high dose male
mice occurred in a high incidence only in the liver.
There was an increased incidence of glandular
ftu mialsXX4Xl IUllUI
The incidence oftotal malignant tumors was also
increased in male mice given the low dose ofchloro-
form; however, mostofthe increase was carcinomas
ofthe liver. The incidence inthe mice on chloroform
was 52% (24/46), compared with none in the vehicle
control male mice.
Tumors of the kidney were seen in 3 of 44 male
mice (7%) on the high dose ofchloroform, as well as
inone male mouse in each ofthe lowdose group, the
vehicle control group, and the untreated group. The
renal tumors inthe highdose groupwere much larger
and more malignant than in the other groups.
Lesions Other Than Tumors
Thrombosis ofthe atrium ofthe heart was present
in 9of40 female mice (23%) (p = 0.0013) on the high
dose of chloroform and not in any other female or
male mice (positive trend 0.0001; departure from
trend 0.0189). Those nine mice also had carcinomas
ofthe liver. Thrombosis ofthe heart is undoubtedly
Table 21. Incidences of malignant lymphomas in male and female mice given chloroform.8
Dose Males Females
0 0/17 0/20 (0%)
Vehicle 0/17 (0%) 0/19 (0%)
Low dose 14/46 (30%), p = 0.00642 9/45 (20%Yo), p = 0.03217
(p = 0.00016) (p = 0.00241)
High dose 10/44 (23%) p = 0.02751 4/40 (10%) (p = 0.06082)
p = 0.0257 p = 0.0262b
ap values in parentheses are for treated rats compared to pooled controls.
bDeparture from trend.
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Dose Males Females
0 0/17 (09o) 0/20 (O%o)
Vehicle 1/17 (6%) 1/19 (5%)
Low dose 11/46 (24%), p = 0.09956 11/45 (24%)c, p = 0.06747
High dose 4/44 (9o) 3/40 (8%)d
p = 0.00248e p = 0.0117e
aCarcinomas of lung, kidney, adrenal (cortical and malignant pheochromocytoma), anal (adenocarcinoma and sebaceous), and
stomach (adenocarcinoma); subcutaneous leiomyosarcoma with metastases to liver and lungs.
bp = 0.00817 when treated rats are compared with the pooled controls.
cEight mice with stomal cell sarcomas of the uterus.
dTwo mice with stromal cell sarcomas of the uterus; p = 0.00376 when the treated rats are compared with the pooled controls.
eDeparture from trend.
related to chloroform treatment, because of the ex-
tremely rare occurrence ofthis lesion incontrol mice
and in large numbers of mice given several other
organochlorine chemicals.
Summary
Chloroform is carcinogenic in mice. Female and
male mice developed high incidences, 100% in the
high dose groups, ofcarcinomas ofthe liver. Female
mice were more susceptible than male mice: Female
mice also had an extremely rare lesion, thrombosis
of the heart.
Huntington Research Center
Chloroform Studies
In a preliminary report Roe described studies in
whichchloroform wasadministered tofour strains of
mice. Sprague-Dawley rats, and beagles (5-7).
ICI-Swiss Mouse Studies
ICI-Swiss male andfemale mice, 52 in each group,
were given 17 or 60 mg/kg/day ofchloroform for 80
weeks. The chemical was given to 3 to 10 week old
mice in atoothpaste base by gavage six days a week.
Animals were killed after 96 weeks.
Eight of37 (22%) male mice given the high dose (p
= 0.00012) of chloroform developed tumors of the
kidney compared to none in the controls (Table 23).
Some of the tumors which were described as
"adenomatous" were large and some mice had mul-
tiple tumors. Some of the tumors of the kidney had
previously been described as malignant tumors, i.e.,
carcinomas by Roe (6). There was also a slight in-
crease in the incidence ofhepatic tumors in males on
both doses ofchloroform. There was no increase in
renal or hepatic tumors in female mice.
There was asignificantincrease inthe incidence of
"hepatic degeneration" (p
= <0.05) in male mice
given 60 mg/kg chloroform.
In summary, chloroform is carcinogenic for the
kidney of ICI-Swiss male mice. In addition, there
was significant "hepatic degeneration."
Other Mouse Studies
The carcinogenicity ofchloroform was studied in
four strains of specific pathogen free mice. Male
ICI-Swiss, C57BL, CBA, and CFI mice 3 to 10
weeks ofage weregiven 60 mg/kg-day ofchloroform
for 80 weeks and killed after 93 to 104 weeks. The
chemical wasgivenintoothpaste base(withessential
oils and 3.6% chloroform) by gavage six times per
week. There were 52 mice in each group.
The incidences ofrenal orhepatic tumors were not
increased in C57BL, CBA, or CFI mice given
chloroform (Table 24). ICI-Swiss male mice (5 of47)
given chloroform developed an increased incidence
of renal tumors; however, 1 of49 control mice also
had a renal tumor. Chronic renal disease was a
''prominent feature" in chloroform-treated and
control mice ofthe ICI-Swiss s-train. The presence or
Table 23. Incidence ofhepatic and renal tumors in male ICI-swiss mice given chloroform.
Dose, mg/kg Hepatic tumors Renal tumors Total tumors
0 5/70 (7%) 0/70 (0o) 5/70 (7%)
17 5/35 (14%) 0/35 (09o) 5/35 (14%)
60 5/37 (14%) 8/37 (22%), p = 0.00012 13/37 (35%), p = 0.00042
p = 0.1151 x 10-4 p = 0.214 x 10-3
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mentioned.
Chloroform treatment did cause a highly signifi-
cant increase in the incidence of chronic renal dis-
ease in CBA (p = <0.01) and CFI (p = <0.001) male
mice. Relatively few CFI mice survived beyond the
80thweekwhenrenal neoplasiawasmostlikelytobe
seen. By the end ofthe first year 51% ofthe treated
and control mice had died, and only six mice were
alive at the termination of the study. Renal disease
may have caused the high mortality.
The renal disease was "chronic nephritis" and
varied in degree from mild and moderate to severe.
The severe disease was described as: "The most
severely affected kidneys were usually visibly en-
larged and had surfaces that were irregular because
offibrotic scarring orcyst formation. In afew cases,
widespread necrosis and fibrosis had led to kidneys
appearing shrunken. Microscopically, severely dis-
eased kidneys showed both tubular and glomerular
changes. Some glomeruli were greatly enlarged and
were infiltrated by lymphocytes. Some showed
thickening of Bowman's capsule. Extensive tubular
changes with areas ofdegeneration and hyperplasia,
numerous tubular casts, fibrosis, and chronic in-
flammatory infiltration were also usually promi-
nent."
In summary, chloroform in toothpaste base was
carcinogenic for the kidney ofmale ICI-Swiss mice,
thus confirming the findings in the previous study
using mice of this strain. Male CBA and CFI mice
givenchloroformdeveloped significantchronic renal
disease, whereas male C57BL did not.
Chloroform Administered With Arachis Oil
The carcinogenicity of chloroform (4%) with
arachis oil as a vehicle was examined for ICI-Swiss
male mice in the previous study. The dose of
Table 24. Incidence ofhepaticand renal tumors in male ICI-Swiss,
C57BL, CBA, and CFI mice given chloroform (60 mg/kg).a
Strain Treatmentb Hepatic tumors Renal tumors
ICI-Swiss (-) 7/49 (14%) 1/49 (2%)
ICI-Swiss (+) 10/47 (21%) 5/47 (11%)
CBA (-) 36/51 (71%) 0/51 (0o)
CBA (+) 29/51 (57%) 0/51 (0%0)
CFI (-) 4/45 (4%) 2/45 (4%)
CFI (+) 5/48 (14%) 1/48 (2%)
C57BL (-) 2/46 (4%) 0/46 (O%o)
C57BL (+) 0/51 (0%) 0/51 (0%)
"The numbers of mice have not been corrected for survival
time, i.e., time ofappearance offirst renal or hepatic tumor. The
earliest renal tumor was observed in achloroform-treated mouse
dying during the 71st week.
bControl micereceivedthetoothpastebasewithoutchloroform.
Table 25. Incidence ofhepatic and renal tumors in male
ICI-Swiss male rats given chloroform in arachis oila
Dose, mg/kg Hepatic tumors Renal tumors
0 8/83 (10%) 0/83 (0%o)
9/133 (7%)
Vehicle 1/50 (2%) 9/50 (18%)
60 8/48 (17%), p = 0.04699b 12/48(25%),p = 0.00156c
p = 0.01305
aNumbers of mice have not been corrected for survival time,
i.e.,timeofappearanceoffirst renalorhepatictumor. Theearliest
renal tumor was found in a dead mouse at 71 weeks.
bp = 0.01305 using vehicle controls only. eStatistics based on combined controls.
chloroform was 60 mg/kg-day. The chemical was
given by oral gavage six days a week for atotal of80
weeks, followed by a 24-week period without the
chemical. A group of 100 untreated mice was also
used for controls.
Twelve of48 mice (25%) developed tumors ofthe
kidney, whereas 1 of 50 (2%) receiving the vehicle
and none of the untreated mice had renal tumors
(Table 25). Eight of 48 (17%) treated mice had he-
patictumors, comparedto9of133 (7%)controls(p =
0.04699).
In summary, chloroform in arachis oil was car-
cinogenic for the kidney of male ICI-Swiss mice.
These results represent the third time that chloro-
form was carcinogenic for the kidney of male ICI-
Swiss mice.
Sprague-Dawley Rats
Sprague-Dawley male and female rats, 50 per
group, were given 60 mg/kg/day ofchloroform for95
weeks. The chemical was given to six-week-old rats
intoothpaste base by gavage six times aweek. There
were 50 rats in each group.
Roe concluded thatthere was no "effect on tumor
incidenceineithersex," andtherewasnoincrease in
hepatic or renal tumors in chloroform-treated rats.
One female rat had a "cystadenoma of the liver."
Benign and malignant tumors were not evaluated
separately. Plasma cholinesterase levels were de-
creased in male and female rats given 60 mg/kg of
chloroform, as well as female rats on 15 mg/kg. Con-
trol rats had a high incidence of tumors.
Beagle Seven and One-Half Year Study
Male and female beagle dogs were given 15 mg/kg
or30 mg/kg/day ofchloroform in toothpaste base for
376weeks, and were killed after396-400 weeks. The
chemical was given in capsules six days a week.
Treatment with chloroform did not affect the sur-
vival of dogs. The SGPT values in dogs given 30
mg/kg of chloroform were two times those in con-
trols.
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Dose, mg/kg Males Females Total
0 0/8 (O%) 0/8 (O0o) 0/16 (%o)
Vehicle 0/16 (0o) 2/16 (13%) 2/32 (6%)
15 1/8 (13%) 3/8 (38%) 4/16 (25%)
30 2/8 (25%) 0/8 (0o) 2/16 (13%)
15-30 3/16 (19%o) 3/16 (9o) 6/16 (37%)
p = 0.0378a
aDeparture from trend.
Neoplasms were seen in 2 ofthe highdose, 4ofthe
low dose ofchloroform, and 2 ofthe dogs receiving
the vehicle (Table 26). Tumors were not present in
untreated dogs. Ofthe chloroform-treated male dogs
l9o (3/16) developed tumors, compared to 0 of 16
dogs in the vehicle and 0 of8 untreated dogs. Three
of 16 female dogs (19%) given chloroform had
tumors, whereas 2 of 16 (13%) dogs on the vehicle
and 0 of 16 untreated dogs had tumors. "Tri-
choepithelioma ofthe skin and hemangiosarcoma of
the spleen" were seen in the two male dogs on the
high dose.
In addition to tumors: "A variety of liver abnor-
malities was seen in both control and treated dogs,
including slight bile-duct hyperplasia, nodules of
enlarged pale-staining, vacuolated or dark-staining
hepatocytes, and a type of lesion that has been de-
scribed in the literature as 'fatty cyst'."
Roe concluded that "no dog in the experiment
developed a neoplasm of the liver." However,
further data are required in order to accurately as-
sess the hepatic nodules in the dogs.
In summary, there was an increase in tumors in
male and female dogs given chloroform. Hepatic
nodules were observed in some dogs.
Summary
Male ICI-Swiss mice given chloroform develop
renal tumors, as well as "hepatic degeneration."
Significant chronic renal disease was seen in male
CH and CBA mice receicing chloroform. Chloro-
form also induced tumors in beagle dogs.
Other Chloroform Studies
Eschenbrenner Study
Strain A male and female mice were given chloro-
form in doses ranging from 37.5 to 600 mg/kg/day by
gavage once every four days for four months (8).
They were killed one month later. Survival times are
given in Table 27.
"Hepatomas" and cirrhosis occurred in female
strain A mice given the 150 or 300 mg/kg doses of
chloroform (Table 28). Within one day after single
exposures to chloroform, hepatic necrosis was ob-
served in both sexes at the three highest doses, but
not at the two lowest doses. Kidney necrosis was
observed at all doses in males, but not in female
mice.
This studydiddemonstrate thattumors ofthe liver
were observed in female strain A mice under the
conditions of the study. Numbers of mice were
small, duration was limited, and mortality of male
mice was too high in order for tumors to develop.
Rudali Study
Rudali studied the carcinogenic effects of halo-
genated hydrocarbons (9). Chloroform was ad-
ministered to NLC mice ofunspecified sex via gav-
Table 27. Survival of male and female strain A mice given chloroform.
Survival
0 37.5 75 150 300 600
mg/kg mg/kg-day mg/kg-day mg/kg-day mg/kg-day mg/kg-day
Males 5/5 5/5 3/5 0/5 0/5 0/5
Females 5/5 5/5 5/5 3/5 4/5 0/5
Table 28. Incidences of "hepatomas" in male and female strain A niice given chloroform.
Hepatoma incidence
0 37.5 75 150 300 600
mg/kg mg/kg-day mg/kg-day mg/kg-day mg/kg-day mg/kg-day
Males 0/5 0/5 0/3
Females 0/5 0/5 0/5 3/3,p = 0.01786 4/4,p = 0.00794
p = 5.864 x 10-6a
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eachand the animals observedfor 10months. Outof
aninitialgroupof24animals, five survived andthree
had "hepatomas." No control group was reported.
Under the conditions of the study, mice given a
limited exposure to chloroform and observed for a
relatively short duration developed tumors of the
liver.
Roe Study
Anexperimentwascarried outbyRoeetal., using
groups of approximately 50 (C57BL X DBA/2)Fi
mice including equal numbers ofmales and females
(10). Chloroformwasgiven as asingledose of200jig
in0.02mlarachis oilwhenthe mice werelessthan24
hroldoraseightdailydoses of200,gstartingbefore
the mice were 24 hr old. All mice were injected
subcutaneously in the intrascapular region. Sur-
vivors (over 36 mice in each group) were killed be-
tween the 77th and 80th week ofthe experiment and
examined for tumors of all sites. The authors con-
cluded that a small number of tumors of the lung,
liver, and mammary gland and a few cases of
generalized lymphoma were encountered in all
groups,buttheincidence wasnohigherinthetreated
groups than in the control groups. No other lesions
attributable to treatment were observed. This is not
unexpectedbecauseofthe lowdosewhichwasgiven
subcutaneously.
Guinea Pig Study
Guinea pigs were given doses of 35 mg/kg and
some ofthem died during the course of the experi-
ment (11). Five ofthe guinea pigs lived longer than
two months, butonly two ofthese lived longer than
three months. The guinea pigs which died had fatty
change, necrosis, and cirrhosis of the liver.
Summary
Strain A female mice given large doses ofchloro-
formbygavageforafew monthsdevelopedcirrhosis
of the liver and "hepatomas." "Hepatomas" also
werereportedinNLCstrain micegivenchloroform.
Guinea pigs given chloroform had cirrhosis ofthe
liver. It is likely that guinea pigs given a dose of
chloroform over a long period of time would also
develop tumors of the liver.
Comments
The formation and occurrence of tumors in man
and other mammals, such as rats and mice, is quite
similar (12). In tests undertaken to date, it has been
demonstrated that virtually every chemical which
has been found to be carcinogenic in man is also
carcinogenic in one or more mammalian test ani-
mals. Ithas been shown thatifthesecompoundswill
produce neoplasms in one species, they will very
likely produce neoplasms in more than one; thus
adding weight to any finding of carcinogenicity in
tests using any mammalian species.
Sufficient documentation is available on qualita-
tive extrapolation ofanimal data that one must con-
clude that a finding ofcarcinogenicity in one mam-
malian species should be deemed to have relevance
for other mammalian species, including man. This
threatmaynotbemanifestedforupto 30or40years,
given the long latent period of many known human
carcinogens.
Statistical analyses were done by C. W. Riggs, Information
Systems Department, Frederick Cancer Research Center.
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